iopromide and Local Neoplasm Recurrence
iopromide has been researched along with Local Neoplasm Recurrence in 16 studies
iopromide: structure given in first source
iopromide : A dicarboxylic acid diamide that consists of N-methylisophthalamide bearing three iodo substituents at positions 2, 4 and 6, a methoxyacetyl substituent at position 5 and two 2,3-dihydroxypropyl groups attached to the amide nitrogens. A water soluble x-ray contrast agent for intravascular administration.
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
"Although hepatocellular carcinoma (HCC) demonstrates characteristic hypervascularity, some HCCs have a hypovascular pattern on computed tomography (CT)." | 1.38 | Prognostic implications of tumor vascularity and its relationship to cytokeratin 19 expression in patients with hepatocellular carcinoma. ( Chung, GE; Jang, JJ; Kim, SH; Kim, YJ; Lee, HS; Lee, JH; Lee, JM; Lee, K; Myung, SJ; Suh, KS; Yoon, JH, 2012) |
"Most patients whose lung cancers are resected have a local or distant recurrence, as determined postoperatively, or show residual or local disease at the time of autopsy." | 1.35 | Evaluation of factors relating to tumor recurrence and survival after resection of lung cancer. ( Bae, YA; Im, HJ; Jeon, YH; Kim, ES; Lee, IJ; Lee, JW, 2009) |
"Thirty-three female patients with breast cancer and suspicion of recurrence underwent FDG-PET-CT and WB-MRI." | 1.35 | Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT. ( Bauerfeind, I; Baur-Melnyk, A; Haug, A; Heinemann, V; Reiser, MF; Schmidt, GP; Schoenberg, SO, 2008) |
Research
Studies (16)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (6.25) | 18.2507 |
2000's | 6 (37.50) | 29.6817 |
2010's | 7 (43.75) | 24.3611 |
2020's | 2 (12.50) | 2.80 |
Authors
Authors | Studies |
---|---|
Muenzfeld, H | 1 |
Mahjoub, S | 1 |
Roehle, R | 1 |
Pelzer, U | 1 |
Bahra, M | 1 |
Boening, G | 1 |
Hamm, B | 1 |
Geisel, D | 1 |
Auer, TA | 1 |
Hu, HT | 1 |
Shan, QY | 1 |
Chen, SL | 1 |
Li, B | 1 |
Feng, ST | 1 |
Xu, EJ | 1 |
Li, X | 1 |
Long, JY | 1 |
Xie, XY | 1 |
Lu, MD | 1 |
Kuang, M | 1 |
Shen, JX | 1 |
Wang, W | 1 |
Pietragalla, M | 1 |
Nardi, C | 1 |
Bonasera, L | 1 |
Mungai, F | 1 |
Verrone, GB | 1 |
Calistri, L | 1 |
Taverna, C | 1 |
Novelli, L | 1 |
Locatello, LG | 1 |
Mannelli, G | 1 |
Gallo, O | 1 |
Miele, V | 1 |
Kim, KA | 1 |
Kim, MJ | 1 |
Choi, JY | 1 |
Park, MS | 1 |
Lim, JS | 1 |
Chung, YE | 1 |
Kim, KW | 1 |
Sharma, P | 1 |
Jain, TK | 1 |
Parida, GK | 1 |
Karunanithi, S | 1 |
Patel, C | 1 |
Sharma, A | 1 |
Thulkar, S | 1 |
Julka, PK | 1 |
Bal, C | 1 |
Kumar, R | 1 |
Zhou, Y | 1 |
He, L | 1 |
Huang, Y | 1 |
Chen, S | 1 |
Wu, P | 1 |
Ye, W | 1 |
Liu, Z | 1 |
Liang, C | 1 |
Wieners, G | 1 |
Pech, M | 1 |
Hildebrandt, B | 1 |
Peters, N | 1 |
Nicolaou, A | 1 |
Mohnike, K | 1 |
Seidensticker, M | 1 |
Sawicki, M | 1 |
Wust, P | 1 |
Ricke, J | 1 |
Kim, ES | 1 |
Lee, IJ | 1 |
Bae, YA | 1 |
Lee, JW | 1 |
Im, HJ | 1 |
Jeon, YH | 1 |
Apajalahti, S | 1 |
Hagström, J | 1 |
Lindqvist, C | 1 |
Suomalainen, A | 1 |
Chung, GE | 1 |
Lee, JH | 1 |
Yoon, JH | 1 |
Myung, SJ | 1 |
Lee, K | 1 |
Jang, JJ | 1 |
Lee, JM | 1 |
Kim, SH | 2 |
Suh, KS | 1 |
Kim, YJ | 1 |
Lee, HS | 1 |
Lee, HY | 1 |
Rhim, H | 1 |
Lee, MW | 1 |
Kim, YS | 1 |
Choi, D | 1 |
Park, MJ | 1 |
Kim, YK | 1 |
Lim, HK | 1 |
Stückle, CA | 1 |
Stueckle, CA | 1 |
Koenig, M | 1 |
Haegele, KF | 1 |
Adams, S | 1 |
Heuser, L | 1 |
Kristiansen, C | 1 |
Loft, A | 1 |
Berthelsen, AK | 1 |
Graff, J | 1 |
Lindebjerg, J | 1 |
Bisgaard, C | 1 |
Jakobsen, A | 1 |
Schmidt, GP | 1 |
Baur-Melnyk, A | 1 |
Haug, A | 1 |
Heinemann, V | 1 |
Bauerfeind, I | 1 |
Reiser, MF | 1 |
Schoenberg, SO | 1 |
Blomqvist, L | 1 |
Holm, T | 1 |
Göranson, H | 1 |
Jacobsson, H | 1 |
Ohlsén, H | 1 |
Larsson, SA | 1 |
Clinical Trials (2)
Trial Overview
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
The Artificial Intelligent Prognostic Assessment and Pathological Basis Research of Early Primary Hepatocellular Carcinoma After Minimally Invasive Treatment Based on Multimodal MRI and Clinical Big Data[NCT04299919] | 1,200 participants (Anticipated) | Observational | 2007-04-01 | Active, not recruiting | |||
Recurrence Risk Factors of Early-Stage Hepatocellular Carcinoma After Radio Frequency Ablation: a Multi-center Prospective Case-control Study[NCT02046356] | 139 participants (Actual) | Observational [Patient Registry] | 2014-01-31 | Active, not recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Trials
1 trial available for iopromide and Local Neoplasm Recurrence
Article | Year |
---|---|
Phase II feasibility study on the combination of two different regional treatment approaches in patients with colorectal "liver-only" metastases: hepatic interstitial brachytherapy plus regional chemotherapy.
Topics: Adult; Aged; Brachytherapy; Catheters, Indwelling; Chemotherapy, Cancer, Regional Perfusion; Chi-Squ | 2009 |
Other Studies
15 other studies available for iopromide and Local Neoplasm Recurrence
Article | Year |
---|---|
Split-bolus vs. multiphasic contrast bolus protocol in patients with pancreatic cancer or cholangiocarcinoma.
Topics: Aged; Bile Duct Neoplasms; Bile Ducts; Carcinoma, Pancreatic Ductal; Cholangiocarcinoma; Clinical Pr | 2019 |
CT-based radiomics for preoperative prediction of early recurrent hepatocellular carcinoma: technical reproducibility of acquisition and scanners.
Topics: Adult; Aged; Algorithms; Biomarkers, Tumor; Carcinoma, Hepatocellular; Contrast Media; Female; Hepat | 2020 |
Current role of computed tomography imaging in the evaluation of cartilage invasion by laryngeal carcinoma.
Topics: Aged; Aged, 80 and over; Arytenoid Cartilage; Contrast Media; Cricoid Cartilage; Female; Humans; Ioh | 2020 |
Detection of recurrent hepatocellular carcinoma on post-operative surveillance: comparison of MDCT and gadoxetic acid-enhanced MRI.
Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Gadolinium DTPA; Humans; Iohexol; Liver Neo | 2014 |
Diagnostic accuracy of integrated (18)F-FDG PET/CT for restaging patients with malignant germ cell tumours.
Topics: Adolescent; Adult; Aged; Biomarkers, Tumor; Child; Child, Preschool; Contrast Media; Female; Fluorod | 2014 |
CT-based radiomics signature: a potential biomarker for preoperative prediction of early recurrence in hepatocellular carcinoma.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Hepatocellular; Contrast Media; Female; Hepatectomy; Huma | 2017 |
Evaluation of factors relating to tumor recurrence and survival after resection of lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Contrast Media; Female; Humans; Iohexol; Lu | 2009 |
Computerized tomography findings and recurrence of keratocystic odontogenic tumor of the mandible and maxillofacial region in a series of 46 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Contrast Media; Female; Follow-Up Studies; Humans | 2011 |
Prognostic implications of tumor vascularity and its relationship to cytokeratin 19 expression in patients with hepatocellular carcinoma.
Topics: Biomarkers, Tumor; Carcinoma, Hepatocellular; Chi-Square Distribution; Contrast Media; Female; Human | 2012 |
Early diffuse recurrence of hepatocellular carcinoma after percutaneous radiofrequency ablation: analysis of risk factors.
Topics: Aged; Biopsy; Carcinoma, Hepatocellular; Case-Control Studies; Catheter Ablation; Contrast Media; Di | 2013 |
[Recurrent rectal cancer: diagnosis by contrast enhancement in MD-CT].
Topics: Contrast Media; Data Interpretation, Statistical; Female; Follow-Up Studies; Humans; Iohexol; Male; | 2005 |
[Contrast media kinetic in multi-slice helical CT cannot detect rectal cancer recurrence with certainty].
Topics: Aged; Cicatrix; Contrast Media; Diagnosis, Differential; Humans; Iohexol; Neoplasm Recurrence, Local | 2005 |
PET/CT and histopathologic response to preoperative chemoradiation therapy in locally advanced rectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Combined Modality Therapy; Contrast Media; F | 2008 |
Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT.
Topics: Adult; Aged; Breast Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Image Interpr | 2008 |
MR imaging, CT and CEA scintigraphy in the diagnosis of local recurrence of rectal carcinoma.
Topics: Aged; Contrast Media; Female; Gadolinium DTPA; Humans; Iohexol; Magnetic Resonance Imaging; Male; Ne | 1996 |